Reference priceEUR €170.50Original source price: INR 15,500.00. Converted estimates are available by currency selection.
| Brand | Hepcludex |
|---|---|
| Manufacturer | MYR GMBH |
| Prescription required | Yes |
Hepcludex 2mg poudre.30flacons x 1(bulevirtide)
bulevirtide
Description
Hepcludex 2mg poudre.30flacons x 1(bulevirtide) is a medicine catalog record in the MediPriceHub database. Active ingredient: bulevirtide. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: MYR GMBH. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis B Vaccine. Pack information: 2 30 x 1. Origin country or market: France. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
HEPCLUDEX is indicated for the treatment of chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or with compensated cirrhosis. This indication is approved under accelerated approval based on a decrease in HDV RNA and alanine aminotransferase (ALT) normalization [see Clinical Studies ] . An improvement in disease-related clinical outcomes has not been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).How to Use
Use bulevirtide under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: bulevirtide. Pack size: 2 30 x 1. Pack unit: box. Manufacturer: MYR GMBH. Origin country: France. Source category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis B Vaccine. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Anti-infective medicines may cause nausea, diarrhea, abdominal discomfort, headache, rash, allergic reactions, liver enzyme changes, interactions with other medicines, or organism-specific resistance concerns. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.